Consistent with our in vitro model of CLL-stroma interactions, we found that CLL patient-derived RSE subsets presented increased GPX4 and GCLC expression, along with increased GSH content. This evidence concerns the gene GPX4 and B-cell chronic lymphocytic leukemia.